Day 1
Thursday, September 17, 2026
Registration/ Breakfast
7:00-7:30 am
Welcome From Course Directors
Shruti Gupta; Raad Chowdhury
7:30-7:45 am
What Do BMT Docs Wish Nephrologists Knew about HSCT?
Corey Cutler
7:45-8:10 am
Changing Diagnostic and Treatment Landscape of HSCT-TMA
Sumithra Vasu
8:10-8:35 am
Cancer and Complementology
Anuja Java
8:35-9:00 am
Murine Models and Immune Therapy: What Can Mice Teach us About AIN?
Sandra Herrmann
9:00-9:25 am
Break
9:25-9:40 am
Beyond Biopsy: Biomarkers and Treatments for ICI-AKI
Meghan Sise
9:40-10:05 am
Lessons from Non-Renal Immune Related Adverse Events
Elad Sharon
10:05-10:30 am
ICI-GN: A Conundrum
Meghan Sise; Shruti Gupta; Abdullah Jalal; Ala Abudayyeh
10:30-11:10 am
Lunch Break/ Poster Review
11:10 am-12:10 pm
Toxicities of CAR-T and CAR-Treg
Sarah Nikiforow
12:10-12:30 pm
How Tumor Infiltrating Lymphocytes are Transforming Cancer Treatment
Allison Betof
12:30-12:50 pm
Q&A
Sarah Nikiforow; Allison Betof
12:50-1:00 pm
MAGnificent properties of Cisplatin: mitigating risk and managing AKI
Edgar Jaimes
1:00-1:25 pm
Target Trial Emulation in Onconephrology
David Leaf
1:25-1:50 pm
What’s the GFR!? Current Challenges in Cancer and Future Opportunities
Aisha Shaikh
1:50-2:15 pm
How Would I Dose Chemotherapy? A Case Review
Abhijat Kitchlu
2:15-2:40 pm
Break
2:40-2:50 pm
Podocytes: An Innocent Bystander in Cancer
Astrid Weins
2:50-3:15 pm
Novel Treatments for Proteinuria and Hypertension: Is there a Role for Endothelin Inhibitors ?
Api Chewcharat
3:15-3:40 pm
SGLT2is: Are they a Miracle For Cancer- Associated Nephrotoxicity Too?
María José Soler
3:40-4:05 pm
Immune Complex Disease in Cancer: Future of Antigens
Sujal Shah
4:05-4:30 pm
Nephrocentric vs Nephrotolerant: When is it Safe to Rechallenge?
Biruh Workeneh; Astrid Weins; Harish Seethapathy; Aisha Shaikh
4:30-5:10 pm
Palliative Care in Onconephrology: Symptom Management and Decision Support
Samantha Gelfand
5:10-5:35 pm
Adjourn
5:35-5:45 pm
Day 2
Friday, September 18, 2026
Registration/Breakfast
7:00-7:30 am
The Other Renal Amyloids: It’s not ALL about AL Amyloid
Vaishali Sanchorawala
7:30-7:55 am
Pathophysiology of Cancer Therapy and Cardiotoxicity
Anju Nohria
7:55-8:20 am
MGUS to Myeloma: Bench to the Bedside
Nikhil Munshi
8:20-8:45 am
IKMG Update on MGRS: Future Associations and Mechanisms
Samih H. Nasr
8:45-9:05 am
How do Immunoglobulins Cause Kidney Damage?
Christophe Sirac
9:05-9:25 am
Q&A
Samih H. Nasr; Christophe Sirac
9:25-9:35 am
Break
9:35-9:45 am
The Onconephrology VS Artificial Intelligence Challenge
Shruti Gupta; Kenar Jhaveri
9:45-10:10 am
How I Manage IgM Disease and Systemic Impact
Jorge J. Castillo
10:10-10:35 am
Light Chain Cast Nephropathy: Beyond Plex (CAR-T, Bispecific)
Nelson Leung
10:35-11:00 am
Kidney Transplant Outcomes in Monoclonal Disorders
11:00-11:25 am
Post Kidney Transplant Lymphoproliferative Disorders: Perspectives from a Transplant Nephrologist
Christopher Blosser
11:25-11:50 am
Clone Wars Case Debate Case: PLEX or NO Plex
Raad Chowdhury; Sujal Shah; Nelson Leung; Kenar Jhaveri
11:50 am-12:30 pm
Final Reflections/Poster Winners
12:30-12:40 pm